TELA Bio (TELA) Cash from Financing Activities (2018 - 2026)
TELA Bio (TELA) posted quarterly Cash from Financing Activities of -$298000.0 for Q1 2026, down 156.9% year-over-year from $523757.6 in Q1 2025, and down 101.15% quarter-over-quarter from $25.8 million in Q4 2025.
TELA Bio (TELA) Cash from Financing Activities (2018 - 2026) Analysis & Trends
TELA Bio's Cash from Financing Activities history runs 9 years deep, the most recent figure standing at -$298000.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 156.9% year-over-year to -$298000.0; the TTM figure through Mar 2026 stood at $25.6 million (down 40.38% YoY), while the FY2025 annual figure was $25.8 million, down 40.2% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$298000.0, down from $25.8 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $46.4 million in Q2 2023, with the low at -$298000.0 in Q1 2026.
- The 5-year median for Cash from Financing Activities is $24000.0 (2025), against an average of $9.2 million.
- The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities sank 505.56% in 2022, then jumped 194936.36% in 2024.
- TELA Bio's Cash from Financing Activities stood at -$219000.0 in 2022, then jumped by 110.05% to $22000.0 in 2023, then surged by 194936.36% to $42.9 million in 2024, then plunged by 39.77% to $25.8 million in 2025, then plunged by 101.15% to -$298000.0 in 2026.
- Business Quant data shows TELA's Cash from Financing Activities at -$298000.0 in Q1 2026, $25.8 million in Q4 2025, and $24000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | -213.50 Mn |
| 10 | TELA Bio | 37.05 Mn | 6.63 Mn | 13.94 Mn | -15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -15,000.00 |
| Jun 30, 2026 | -15,000.00 |
| Mar 31, 2026 | -298,000.00 |
| Mar 31, 2026 | -298,000.00 |
| Dec 31, 2025 | 25.85 Mn |
| Dec 31, 2025 | 25.85 Mn |
| Sep 30, 2025 | 24,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Jun 30, 2025 | -3,000.00 |
| Jun 30, 2025 | -3,000.00 |
| Mar 31, 2025 | -116,000.00 |
| Mar 31, 2025 | -116,000.00 |
| Dec 31, 2024 | 42.91 Mn |
| Dec 31, 2024 | 42.91 Mn |
| Sep 30, 2024 | 98,000.00 |
| Sep 30, 2024 | 98,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | 56,000.00 |
| Mar 31, 2024 | 56,000.00 |